Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q2 2018 · 10-Q
Revenue$6.53M$6.53M+4.6% vs Q2 2017 Net Income$539.51K$539.51K+8.6% vs Q2 2017 EPS Diluted$0.07$0.07+16.7% vs Q2 2017 Operating Income$1,149,736−3.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$32,032−98.4% Margins · derivedOperating margin17.6%−1.5 pt vs Q2 2017
Net margin8.3%+0.3 pt vs Q2 2017
ended May 31, 2018 · filed Jul 16, 2018 · 46 d after period end